Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases

María Asunción Esteve-Pastor; Eva Soler-Espejo; Francisco Marín

doi:10.1055/a-2170-1892

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2024; 124(04): 320-323
DOI: 10.1055/a-2170-1892

Invited Editorial Focus

Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases

María Asunción Esteve-Pastor

¹Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Pascual Parrilla), CIBERCV, University of Murcia, Murcia, Spain

,

Eva Soler-Espejo

²Department of Hematology, Hospital General Universitario Morales Meseguer, Instituto Murciano de Investigación Biosanitaria (IMIB-Pascual Parrilla) , University of Murcia, Murcia, Spain

,

Francisco Marín

¹Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Pascual Parrilla), CIBERCV, University of Murcia, Murcia, Spain

› Author Affiliations

Abstract

Full Text

References

References
1 Ingram M, Coopersmith A. Reticulated platelets following acute blood loss. Br J Haematol 1969; 17 (03) 225-229
2 Grove EL, Hvas AM, Kristensen SD. Immature platelets in patients with acute coronary syndromes. Thromb Haemost 2009; 101 (01) 151-156
3 Lakkis N, Dokainish H, Abuzahra M. et al. Reticulated platelets in acute coronary syndrome: a marker of platelet activity. J Am Coll Cardiol 2004; 44 (10) 2091-2093
4 Clancy L, Beaulieu LM, Tanriverdi K, Freedman JE. The role of RNA uptake in platelet heterogeneity. Thromb Haemost 2017; 117 (05) 948-961
5 Garishah FM, Huskens D, Pramudo SG. et al. Hyperresponsive platelets and a reduced platelet granule release capacity are associated with severity and mortality in COVID-19 patients. Thromb Haemost 2022; 122 (12) 2001-2010
6 Linge CP, Jern A, Tydén H. et al. Enrichment of complement, immunoglobulins, and autoantibody targets in the proteome of platelets from patients with systemic lupus erythematosus. Thromb Haemost 2022; 122 (09) 1486-1501
7 Geisler T. Insights into release of interleukin-1β from platelets. Thromb Haemost 2022; 122 (04) 475
8 Thiele T, Handtke S. COAT platelets under alarm. Thromb Haemost 2021; 121 (10) 1267
9 Agbani EO, Schneider P, McDonald B, Skeith L, Poon MC, Lee A. Activated platelets harbor SARS-CoV-2 during severe COVID-19. Thromb Haemost 2022; 122 (02) 308-309
10 Cesari F, Marcucci R, Gori AM. et al. Reticulated platelets predict cardiovascular death in acute coronary syndrome patients. Insights from the AMI-Florence 2 study. Thromb Haemost 2013; 109 (05) 846-853
11 Bongiovanni D, Santamaria G, Klug M. et al. Transcriptome analysis of reticulated platelets reveals a prothrombotic profile. Thromb Haemost 2019; 119 (11) 1795-1806
12 Faber J, Hvas AM, Kristensen SD, Grove EL, Adelborg K. Immature platelets and risk of cardiovascular events among patients with ischemic heart disease: a systematic review. Thromb Haemost 2021; 121 (05) 659-675
13 Handtke S, Steil L, Palankar R. et al. Role of platelet size revisited-function and protein composition of large and small platelets. Thromb Haemost 2019; 119 (03) 407-420
14 Hannawi B, Hannawi Y, Kleiman NS. Reticulated platelets: changing focus from basics to outcomes. Thromb Haemost 2018; 118 (09) 1517-1527
15 Bongiovanni D, Novelli L, Condello F. et al. Reticulated platelets predict cardiovascular death and adverse events in coronary artery disease: a systematic review and meta-analysis. Thromb Haemost 2024; 124 (04) 310-319
16 Zhao Y, Lai R, Zhang Y, Shi D. The prognostic value of reticulated platelets in patients with coronary artery disease: a systematic review and meta-analysis. Front Cardiovasc Med 2020; 7: 578041
17 Pedersen OB, Larsen SB, Kristensen SD, Hvas AM, Grove EL. Immature platelets and cardiovascular events in patients with stable coronary artery disease. Platelets 2023; 34 (01) 2217960
18 Corpataux N, Franke K, Kille A. et al. Reticulated platelets in medicine: current evidence and further perspectives. J Clin Med 2020; 9 (11) 3737
19 Leader A, Pereg D, Lishner M. Are platelet volume indices of clinical use? A multidisciplinary review. Ann Med 2012; 44 (08) 805-816
20 Papanas N, Symeonidis G, Maltezos E. et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004; 15 (08) 475-478
21 Jiménez MM, Guedán MJ, Martín LM, Campos JA, Martínez IR, Vilella CT. Measurement of reticulated platelets by simple flow cytometry: an indirect thrombocytopoietic marker. Eur J Intern Med 2006; 17 (08) 541-544
22 Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357 (24) 2482-2494
23 Gurbel PA, Serebruany VL, Komjathy SF. et al. Regional and systemic platelet function is altered by myocardial ischemia-reperfusion. J Thromb Thrombolysis 1995; 1 (02) 187-194
24 Alexopoulos D, Xenogiannis I, Vlachakis P, Tantry U, Gurbel PA. Peri-procedural platelet reactivity in percutaneous coronary intervention. Thromb Haemost 2018; 118 (07) 1131-1140
25 Stratz C, Nührenberg T, Valina CM. et al. Impact of reticulated platelets on the antiplatelet effect of the intravenous P2Y12-receptor inhibitor cangrelor. Thromb Haemost 2018; 118 (02) 362-368
26 Stratz C, Nührenberg T, Amann M. et al. Impact of reticulated platelets on antiplatelet response to thienopyridines is independent of platelet turnover. Thromb Haemost 2016; 116 (05) 941-948
27 Lordkipanidzé M, Pharand C, Schampaert E, Palisaitis DA, Diodati JG. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease. Int J Cardiol 2011; 150 (01) 39-44
28 Guthikonda S, Alviar CL, Vaduganathan M. et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008; 52 (09) 743-749
29 Perl L, Lerman-Shivek H, Rechavia E. et al. Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2014; 63 (06) 513-517
30 Bernlochner I, Goedel A, Plischke C. et al. Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome. Eur Heart J 2015; 36 (45) 3202-3210